The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors Dealings

1 Dec 2020 11:52

RNS Number : 1238H
Adamas Finance Asia Limited
01 December 2020
 

 

 

1 December 2020

ADAMAS FINANCE ASIA LIMITED

("ADAM" or the "Company")

Director Dealings

The Company has been notified on 29 November 2020 that Mr. John Croft, Executive Chairman of the Company, has purchased a total of 33,000 ordinary shares at a weighted average price of 21.47 pence per ordinary share. The purchases, all part of one order, took place on 20th November (3,500 shares), 23rd November (10,500 shares), and 27th November 2020 (19,000 shares), respectively. Following these transactions, Mr. John Croft holds 118,463 ordinary shares representing 0.10% of the voting rights in the issued share capital of the Company, excluding shares held in treasury.

For further information on ADAM, please visit the Company's website at http://adamasfinance.com and follow the Company on Twitter (@AdamasFinance).

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 

Adamas Finance Asia Limited

+44 (0) 778 531 5588

John Croft

 

 

 

WH Ireland Limited - Nominated Adviser

+44 (0) 20 7220 1666

James Joyce

 

James Sinclair-Ford

 

 

 

Pello Capital Limited - Corporate Broker

+44 (0) 20 3700 2500

Mark Treharne

 

 

About Adamas Finance Asia

Adamas Finance Asia Limited (ADAM) is quoted on the AIM Market of the London Stock Exchange and is committed to providing shareholders with attractive uncorrelated, risk adjusted long-term returns from a combination of realising sustainable capital growth and delivering dividend income.

 

The Company is focused on providing growth capital and financing to emerging and established Small and Medium Enterprises (SME) sector throughout Asia, well diversified by national geographies, instruments and asset classes. This vital segment of the economy is underserved by the traditional banking industry for regulatory and structural reasons.

 

The Company's investment manager, Harmony Capital, seeks to capitalise on its team's established investment expertise and broad networks across Asia. Through rigorous diligence and disciplined risk management, Harmony Capital is dedicated to delivering attractive income and capital growth for shareholders with significant downside protection through selectively investing in assets and proactively managing them.

 

Harmony Capital is predominately sourcing private opportunities and continues to create a strong pipeline of attractive income generating assets from potential investments in growth sectors across Asia, including healthcare, fintech, hospitality, IT and property. 

 

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

John Croft

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Adamas Finance Asia Limited

b)

LEI

2138005R4IVX4O3IQ543

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares at a weighted average price of 21.47p each 

 

 

VGG008271246

b)

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

20.22p

21.67p

21.59p

 

3,500

10,500

19,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

33,000

GBP 7,085

e)

Date of the transaction

20th,23rd and 27th November 2020

f)

Place of the transaction

London Stock Exchange

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDZMGZMMLGGZM
Date   Source Headline
4th Jul 20137:00 amRNSCo-investment plan with Adamas
28th Jun 201310:36 amRNSAnnual Report and Notice of AGM
27th Jun 20134:44 pmRNSFinal Results
24th Jun 20135:25 pmRNSReduction in Net Asset Value
8th May 20134:40 pmRNSSecond Price Monitoring Extn
8th May 20134:35 pmRNSPrice Monitoring Extension
8th May 20132:41 pmRNSInvestment in Asia Bioenergy Technologies Berhad
7th May 201311:27 amRNSIssue of Equity
29th Apr 201312:03 pmRNSIssue of Equity and Total Voting Rights
15th Apr 20133:45 pmRNSIssue of Equity
5th Mar 20132:13 pmRNSHolding(s) in Company
14th Feb 201310:41 amRNSDirectorate Change
8th Feb 20131:41 pmRNSInvestment in Patimas Computer Berhad
31st Dec 20127:00 amRNSDirector/PDMR Shareholding
24th Dec 201210:34 amRNSDirector/PDMR Shareholding
18th Dec 201211:57 amRNSDirector/PDMR Shareholding
17th Dec 20129:43 amRNSResignation of Director
6th Dec 20127:00 amRNSQuote on Open Market of Frankfurt Stock Exchange
5th Dec 20129:51 amRNSOption Agreement
23rd Nov 20127:00 amRNSDirector/PDMR Shareholding
22nd Nov 20128:00 amRNSStrategic Partnership
15th Oct 20127:00 amRNSRestructuring of Enfinium Investment
4th Oct 201211:58 amRNSPosting of Interim Report
28th Sep 20126:27 pmRNSMr Duncan Chui
26th Sep 201212:36 pmRNSHalf Yearly Report
11th Sep 20124:40 pmRNSSecond Price Monitoring Extn
11th Sep 20124:35 pmRNSPrice Monitoring Extension
28th Aug 20121:23 pmRNSMr Duncan Chui
22nd Aug 20124:40 pmRNSSecond Price Monitoring Extn
22nd Aug 20124:38 pmRNSPrice Monitoring Extension
30th Jul 201210:40 amRNSAGM Statement
16th Jul 20124:18 pmRNSUnusual Share Price Movements
28th Jun 201212:03 pmRNSNotice of AGM and Posting of Annual Report
22nd Jun 20121:11 pmRNSFinal Results
15th Jun 201211:45 amRNSNotice of Results & NAV Update
28th May 201210:41 amRNSKey Strategic co-operation deal with China's Hunan
28th Feb 20127:00 amRNSChange of Adviser
9th Jan 20122:05 pmRNSDirectorate Change
21st Dec 201112:38 pmRNSAppointment of Chief Financial Officer
21st Dec 201112:34 pmRNSIssue of Equity
21st Nov 20114:37 pmRNSDirector/PDMR Shareholding
23rd Sep 201110:51 amRNSHalf Yearly Report
15th Jul 201112:35 pmRNSAGM Statement
22nd Jun 20117:00 amRNSNotice of AGM
8th Jun 20117:00 amRNSFinal Results
7th Jun 20115:13 pmRNSHolding(s) in Company - Replacement
7th Jun 201112:14 pmRNSHolding(s) in Company
24th May 20117:00 amRNSTrading Statement
24th May 20117:00 amRNSNotice of Results & Trading Update
5th May 201111:21 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.